Resilience remote monitoring: a Class IIa medical device

Remote monitoring is indeed a medical device allowing the reporting of your patients’ symptoms to their care team and the sending of alerts if necessary. The tool distributed by Resilience is a product regulated under European regulations and certified by the notified body GMED (certification body and a French notified body in Europe) as a Class IIa medical device.

Our software service is indicated for the follow-up of cancer patients with the aim of detecting progression, recurrence or therapeutic toxicity. All the elements that make up our platform have been designed in close compliance with the most stringent international standards in terms of quality management, information system security and medical device software design.

-

Cancer types and treatments managed by Resilience

With its Class IIa medical device certification, Resilience allows the remote monitoring of patients with all types of cancer, for all phases and for all treatments.